Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bank of America Corp (BAC) vs Viatris Inc (VTRS) Price & Performance

Bank of America CorpTrade
Viatris IncTrade

Price performance (Past 24H)

Key statistics

Bank of America Corp vs Viatris Inc — how do they compare? Bank of America Corp trades at $63.96 (market cap $446.56B), while Viatris Inc trades at $16.28 (market cap $18.69B). The key difference: Bank of America Corp is far larger — about 23.9× Viatris Inc's market cap, and Viatris Inc pays the higher dividend (2.95%). Which is the better fit depends on your goals.

BACVTRS
Market Cap
$446.56B$18.69B
Volume
55,637,172
Sector
FinancialsHealth
52-Week High
$64.00$17.86
52-Week Low
$46.72$9.49
Dividend Yield
2%2.95%
Enterprise Value
$30.81B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Bank of America Corp

Bank of America (BAC) trades at $64.00, up 1.31% today, with a bullish technical signal and consistent earnings beats in recent quarters. The stock shows strong fundamentals, including a P/E of 14.75 and net income margin of 28.21%, supported by revenue growth to $113.10 billion in 2025. Recent news highlights partnerships, hiring initiatives, and positive analyst coverage, with a consensus price target of $67.36.

Outlook remains positive with potential upside from capital returns and earnings growth, though risks include macroeconomic sensitivity and high RSI levels. Analyst consensus is strongly bullish with 64.82% buy ratings, indicating confidence in BAC's deposit franchise and operational strength amid evolving rate cycles.

Viatris Inc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Bank of America Corp

Bank of America Corporation operates as a financial holding company. The Company offers saving accounts, deposits, mortgage and construction loans, cash and wealth management, certificates of deposit, investment funds, credit and debit cards, insurance, mobile, and online banking services. Bank of America serves customers worldwide.

Read more on BAC

About Viatris Inc

Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).

Read more on VTRS